TY - JOUR AU - Tao, Y. AU - Daly-Schveitzer, N. AU - Lusinchi, A. AU - Bourhis, J. PY - 2010 DA - 2010// TI - Advances in radiotherapy of head and neck cancers JO - Curr Opin Oncol VL - 22 UR - https://doi.org/10.1097/CCO.0b013e3283388906 DO - 10.1097/CCO.0b013e3283388906 ID - Tao2010 ER - TY - JOUR AU - Pignon, J. P. AU - le Maitre, A. AU - Maillard, E. AU - Bourhis, J. PY - 2009 DA - 2009// TI - Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients JO - Radiother Oncol VL - 92 UR - https://doi.org/10.1016/j.radonc.2009.04.014 DO - 10.1016/j.radonc.2009.04.014 ID - Pignon2009 ER - TY - JOUR AU - Calais, G. AU - Alfonsi, M. AU - Bardet, E. PY - 1999 DA - 1999// TI - Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma JO - J Natl Cancer Inst VL - 91 UR - https://doi.org/10.1093/jnci/91.24.2081 DO - 10.1093/jnci/91.24.2081 ID - Calais1999 ER - TY - JOUR AU - Hennequin, C. AU - Favaudon, V. PY - 2002 DA - 2002// TI - Biological basis for chemo-radiotherapy interactions JO - Eur J Cancer VL - 38 UR - https://doi.org/10.1016/S0959-8049(01)00360-4 DO - 10.1016/S0959-8049(01)00360-4 ID - Hennequin2002 ER - TY - JOUR AU - Hennequin, C. AU - Giocanti, N. AU - Balosso, J. AU - Favaudon, V. PY - 1994 DA - 1994// TI - Interaction of ionizing radiation with the topoisomerase I poison camptothecin in growing V-79 and HeLa cells JO - Cancer Res VL - 54 ID - Hennequin1994 ER - TY - JOUR AU - Giocanti, N. AU - Hennequin, C. AU - Balosso, J. AU - Mahler, M. AU - Favaudon, V. PY - 1993 DA - 1993// TI - DNA repair and cell cycle interactions in radiation sensitization by the topoisomerase II poison etoposide JO - Cancer Res VL - 53 ID - Giocanti1993 ER - TY - JOUR AU - Johnson, D. H. AU - Hainsworth, J. D. AU - Hande, K. R. AU - Greco, F. A. PY - 1991 DA - 1991// TI - Current status of etoposide in the management of small cell lung cancer JO - Cancer VL - 67 UR - https://doi.org/3.0.CO;2-E DO - 3.0.CO;2-E ID - Johnson1991 ER - TY - JOUR AU - Bernier, J. AU - Domenge, C. AU - Ozsahin, M. PY - 2004 DA - 2004// TI - Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer JO - N Engl J Med VL - 350 UR - https://doi.org/10.1056/NEJMoa032641 DO - 10.1056/NEJMoa032641 ID - Bernier2004 ER - TY - JOUR AU - Tobias, J. S. AU - Monson, K. AU - Gupta, N. PY - 2010 DA - 2010// TI - Chemoradiotherapy for locally advanced head and neck cancer: 10-year follow-up of the UK Head and Neck (UKHAN1) trial JO - Lancet Oncol VL - 11 UR - https://doi.org/10.1016/S1470-2045(09)70306-7 DO - 10.1016/S1470-2045(09)70306-7 ID - Tobias2010 ER - TY - JOUR AU - Hoskins, P. J. AU - Swenerton, K. D. PY - 1994 DA - 1994// TI - Oral etoposide is active against platinum-resistant epithelial ovarian cancer JO - J Clin Oncol VL - 12 ID - Hoskins1994 ER - TY - JOUR AU - Gedlicka, C. AU - Kornfehl, J. AU - Turhani, D. AU - Burian, M. AU - Formanek, M. PY - 2006 DA - 2006// TI - Salvage therapy with oral etoposide in recurrent and/or metastatic squamous cell carcinoma of the head and neck JO - Cancer Invest VL - 24 UR - https://doi.org/10.1080/07357900600633734 DO - 10.1080/07357900600633734 ID - Gedlicka2006 ER - TY - JOUR AU - Khafif, A. AU - Canfield, V. A. AU - Syzek, E. J. AU - Medina, J. E. PY - 2003 DA - 2003// TI - Results of phase I-II trial of concomitant hyperfractionated radiation and oral etoposide (VP-16) in patients with unresectable squamous cell carcinoma of the head and neck JO - Am J Otolaryngol VL - 24 UR - https://doi.org/10.1053/ajot.2003.7 DO - 10.1053/ajot.2003.7 ID - Khafif2003 ER - TY - JOUR AU - Zhang, N. AU - Erjala, K. AU - Kulmala, J. PY - 2009 DA - 2009// TI - Concurrent cetuximab, cisplatin, and radiation for squamous cell carcinoma of the head and neck in vitro JO - Radiother Oncol VL - 92 UR - https://doi.org/10.1016/j.radonc.2009.04.019 DO - 10.1016/j.radonc.2009.04.019 ID - Zhang2009 ER - TY - JOUR AU - Tao, Y. AU - Zhang, P. AU - Girdler, F. PY - 2008 DA - 2008// TI - Enhancement of radiation response in p53-deficient cancer cells by the Aurora-B kinase inhibitor AZD1152 JO - Oncogene VL - 27 UR - https://doi.org/10.1038/sj.onc.1210990 DO - 10.1038/sj.onc.1210990 ID - Tao2008 ER - TY - JOUR AU - Tao, Y. AU - Leteur, C. AU - Yang, C. PY - 2009 DA - 2009// TI - Radiosensitization by Chir-124, a selective CHK1 inhibitor: effects of p53 and cell cycle checkpoints JO - Cell Cycle VL - 8 UR - https://doi.org/10.4161/cc.8.8.8203 DO - 10.4161/cc.8.8.8203 ID - Tao2009 ER - TY - JOUR AU - Bonner, J. A. AU - Harari, P. M. AU - Giralt, J. PY - 2006 DA - 2006// TI - Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck JO - N Engl J Med VL - 354 UR - https://doi.org/10.1056/NEJMoa053422 DO - 10.1056/NEJMoa053422 ID - Bonner2006 ER - TY - JOUR AU - Bonner, J. A. AU - Harari, P. M. AU - Giralt, J. PY - 2009 DA - 2009// TI - Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival JO - Lancet Oncol VL - 11 UR - https://doi.org/10.1016/S1470-2045(09)70311-0 DO - 10.1016/S1470-2045(09)70311-0 ID - Bonner2009 ER - TY - JOUR AU - Budach, W. AU - Bolke, E. AU - Homey, B. PY - 2007 DA - 2007// TI - Severe cutaneous reaction during radiation therapy with concurrent cetuximab JO - N Engl J Med VL - 357 UR - https://doi.org/10.1056/NEJMc071075 DO - 10.1056/NEJMc071075 ID - Budach2007 ER - TY - JOUR AU - Pryor, D. I. AU - Porceddu, S. V. AU - Burmeister, B. H. PY - 2009 DA - 2009// TI - Enhanced toxicity with concurrent cetuximab and radiotherapy in head and neck cancer JO - Radiother Oncol VL - 90 UR - https://doi.org/10.1016/j.radonc.2008.09.018 DO - 10.1016/j.radonc.2008.09.018 ID - Pryor2009 ER - TY - JOUR AU - Giro, C. AU - Berger, B. AU - Bolke, E. PY - 2009 DA - 2009// TI - High rate of severe radiation dermatitis during radiation therapy with concurrent cetuximab in head and neck cancer: results of a survey in EORTC institutes JO - Radiother Oncol VL - 90 UR - https://doi.org/10.1016/j.radonc.2008.09.007 DO - 10.1016/j.radonc.2008.09.007 ID - Giro2009 ER - TY - JOUR AU - Merlano, M. C. AU - Russi, E. G. PY - 2009 DA - 2009// TI - Epidermal growth factor receptor-inhibitors and radiotherapy-induced cutaneous adverse effects: "Koebner-Phenomenon" or radio-dermatitis? JO - Radiother Oncol VL - 92 UR - https://doi.org/10.1016/j.radonc.2009.03.001 DO - 10.1016/j.radonc.2009.03.001 ID - Merlano2009 ER - TY - JOUR AU - Klastersky, J. PY - 2006 DA - 2006// TI - Adverse effects of the humanized antibodies used as cancer therapeutics JO - Curr Opin Oncol VL - 18 UR - https://doi.org/10.1097/01.cco.0000228734.32261.62 DO - 10.1097/01.cco.0000228734.32261.62 ID - Klastersky2006 ER - TY - JOUR AU - Lassen, P. AU - Eriksen, J. G. AU - Hamilton-Dutoit, S. AU - Tramm, T. AU - Alsner, J. AU - Overgaard, J. PY - 2010 DA - 2010// TI - HPV-associated p16-expression and response to hypoxic modification of radiotherapy in head and neck cancer JO - Radiother Oncol VL - 94 UR - https://doi.org/10.1016/j.radonc.2009.10.008 DO - 10.1016/j.radonc.2009.10.008 ID - Lassen2010 ER - TY - JOUR AU - Lassen, P. PY - 2010 DA - 2010// TI - The role of Human papillomavirus in head and neck cancer and the impact on radiotherapy outcome JO - Radiother Oncol VL - 95 UR - https://doi.org/10.1016/j.radonc.2010.04.022 DO - 10.1016/j.radonc.2010.04.022 ID - Lassen2010 ER - TY - JOUR AU - de Jong, M. C. AU - Pramana, J. AU - Knegjens, J. L. PY - 2010 DA - 2010// TI - HPV and high-risk gene expression profiles predict response to chemoradiotherapy in head and neck cancer, independent of clinical factors JO - Radiother Oncol VL - 95 UR - https://doi.org/10.1016/j.radonc.2010.02.001 DO - 10.1016/j.radonc.2010.02.001 ID - de Jong2010 ER -